Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

J Eur Acad Dermatol Venereol. 2018 May;32(5):e176-e177. doi: 10.1111/jdv.14678. Epub 2017 Dec 1.

Authors

S Thomas^{1

2}, A Laino^{1

2}, R Sturm¹, K Nufer¹, D Lambie^{2

3}, B Shepherd², V Atkinson⁴, L Adams¹, H P Soyer^{1

2}, H Schaider¹

Affiliations

¹ Dermatology Research Centre, The University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.
² Department of Dermatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
³ IQ Pathology, Brisbane, QLD, Australia.
⁴ Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia.

PMID: 29114959
DOI: 10.1111/jdv.14678

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents, Immunological / therapeutic use*
Humans
Melanoma / diagnostic imaging
Melanoma / drug therapy*
Melanoma / pathology
Neoplasm Metastasis
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Tomography, X-Ray Computed

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Programmed Cell Death 1 Receptor
pembrolizumab